Struggling with myelofibrosis-associated anemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Struggling with myelofibrosis-associated anemia

Published:2013-11 Issue:11 Volume:37 Page:1429-1431
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Guglielmelli Paola,Vannucchi Alessandro M.

Funder

AIRC “Special Program Molecular Clinical Oncology 5×1000” to AGIMM group

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference14 articles.

1. Advances in understanding and management of myeloproliferative neoplasms;Vannucchi;CA Cancer J Clin,2009

2. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment;Cervantes;Blood,2009

3. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment);Passamonti;Blood,2010

4. DIPSS plus: a refined dynamic international prognostic scoring system for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status;Gangat;J Clin Oncol,2011

5. Immunomodulatory agents in myelofibrosis;Tabarroki;Expert Opin Invest Drugs,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biosimilar erythropoiesis‐stimulating agents are an effective and safe option for the management of myelofibrosis‐related anemia;European Journal of Haematology;2022-12-16

2. Abnormally Short Erythrocyte LifeSpan in Three Patients with Primary Myelofibrosis Despite Successful Control of Splenomegaly;The American Journal of the Medical Sciences;2021-02

3. Ruxolitinib in the treatment of patients with myelofibrosis — questions and answers;Oncology in Clinical Practice;2019-06-26

4. Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosis;Current Medical Research and Opinion;2018-01-04

5. Managing patients with myelofibrosis and low platelet counts;Annals of Hematology;2016-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3